Dissecting Clinical Trial and Real-World Data for ADCs in TNBC

Summary: Triple-negative breast cancer (TNBC) can be tough to treat, but doctors are focusing on a smart new tool. They are targeting something called TROP2, which shows up a lot on tumor cells but rarely on healthy ones. Using special medicines called antibody-drug conjugates (ADCs), doctors can deliver strong chemotherapy straight to the cancer cells, leaving the healthy cells alone. A new online course is now available to help doctors and nurses learn how to use these amazing ADCs to treat TNBC in the real world.

Source: rssapp-patientcareonline-com URL: gotoper.com/courses/dissecting-clinical-trial-and-real-world-data-for-adcs-in-tnbc?utm_source=patientcareonline&utm_medium=homePage&utm_campaign=cmeDeck (opens in new tab)